Postmortem diagnosis and toxicological validation of illicit substance use

Addiction Biology

Volumn 13, Issue 1, 2008, Pages 105-117

  Lehrmann, Elin ^a,b   Afanador, Zoan R ^b   Deep Soboslay, Amy ^a   Gallegos, Gloria ^b   Darwin, William D ^b   Lowe, Ross H ^b   Barnes, Allan J ^b   Huestis, Marilyn A ^b   Cadet, Jean L ^b   Herman, Mary M ^a   Hyde, Thomas M ^a   Kleinman, Joel E ^a   Freed, William J ^b  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Addiction; Biological matrix; Drug abuse; Hair toxicology; Postmortem Substance Abuse Assessment Questionnaire; Substance use disorders

Indexed keywords

CANNABIS; COCAINE; ILLICIT DRUG; OPIATE; PHENCYCLIDINE;

ANALYTIC METHOD; ARTICLE; AUTOPSY; BLOOD TOXICITY; BRAIN TOXICITY; COCAINE DEPENDENCE; CONTROLLED STUDY; HAIR ANALYSIS; HUMAN; INTERVIEW; NEUROBIOLOGY; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SUBSTANCE ABUSE; TOXICOLOGICAL PARAMETERS; VALIDATION PROCESS;

AUTOPSY; BODY FLUIDS; CEREBELLUM; COCAINE-RELATED DISORDERS; CORONERS AND MEDICAL EXAMINERS; HAIR; HUMANS; MARIJUANA ABUSE; MEDICAL HISTORY TAKING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OPIOID-RELATED DISORDERS; PHENCYCLIDINE ABUSE; SENSITIVITY AND SPECIFICITY; STREET DRUGS; SUBSTANCE-RELATED DISORDERS;

EID: 38849133675     PISSN: 13556215     EISSN: 13691600     Source Type: Journal    
DOI: 10.1111/j.1369-1600.2007.00085.x     Document Type: Article

References (35)

1. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Press.
2. Chatterji S, Saunders JB, Vrasti R, Grant BF, Hasin D, Mager D (1997) Reliability of the alcohol and drug modules of the alcohol use disorder and associated disabilities interview schedule - alcohol/drug-revised (AUDADIS-ADR): an international comparison. Drug Alcohol Depend 47: 171 185.
3. Conway KP, Compton W, Stinson FS, Grant BF (2006) Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 67: 247 257.
4. Deep-Soboslay A, Akil M, Martin CE, Bigelow LB, Herman MM, Hyde TM, Kleinman JE (2005) Reliability of psychiatric diagnosis in postmortem research. Biol Psychiatry 57: 96 101.
5. First MB, Spitzer RL, Gibbon M, Williams JBW (1997) Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I), Clinician Version, User's Guide. Washington, DC: American Psychiatry Press.
6. Grant BF, Stinson FS, Dawson DA, Chou SP, Dufour MC, Compton W, Pickering RP, Kaplan K (2004) Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 61: 807 816.
7. Hasin D, Samet S, Nunes E, Meydan J, Matseoane K, Waxman R (2006) Diagnosis of comorbid psychiatric disorders in substance users assessed with the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV. Am J Psychiatry 163: 689 696.
8. Henderson GL, Harkey MR, Zhou C, Jones RT, Jacob P III. 1996) Incorporation of isotopically labeled cocaine and metabolites into human hair: 1. Dose-response relationships. J Anal Toxicol 20: 1 12.
9. Hill C, Keks N, Roberts S, Opeskin K, Dean B, MacKinnon A, Copolov D (1996) Problem of diagnosis in postmortem brain studies of schizophrenia. Am J Psychiatry 153: 533 537.
10. Huestis MA, Henningfield JE, Cone EJ (1992) Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana. J Anal Toxicol 116: 276 282.
11. Huestis MA, Mitchell JM, Cone EJ (1996) Urinary excretion profiles of 11-nor-9-carboxy-delta 9-tetrahydrocannabinol in humans after single smoked doses of marijuana. J Anal Toxicol 20: 441 452.
12. Kelly TM, Mann JJ (1996) Validity of DSM-III-R diagnosis by psychological autopsy: a comparison with clinician ante-mortem diagnosis. Acta Psychiatr Scand 94: 337 343.
13. Lehrmann E, Colantuoni C, Deep-Soboslay A, Becker KG, Lowe R, Huestis MA, Hyde TM, Kleinman JE, Freed WJ (2006) Transcriptional changes common to human cocaine, PCP and marijuana abuse. PLoS ONE 1: e114.
14. Lewis DA (2002) The human brain revisited: opportunities and challenges in postmortem studies of psychiatric disorders. Neuropsychopharmacology 26: 143 154.
15. London ED, Simon SL, Berman SM, Mandelkern MA, Lichtman AM, Bramen J, Shinn AK, Miotto K, Learn J, Dong Y, Matochik JA, Kurian V, Newton T, Woods R, Rawson R, Ling W (2004) Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers. Arch Gen Psychiatry 61: 73 84.
16. Lowe RH, Barnes AJ, Lehrmann E, Freed WJ, Kleinman JE, Hyde TM, Herman MM, Huestis MA (2006) A validated positive chemical ionization GC/MS method for the identification and quantification of amphetamine, opiates, cocaine, and metabolites in human postmortem brain. J Mass Spectrom 41: 175 184.
17. McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, Pettinati H, Argeriou M (1992) The fifth edition of the Addiction Severity Index. J Subst Abuse Treat 9: 199 213.
18. Mexal S, Frank M, Berger R, Adams CE, Ross RG, Freedman R, Leonard S (2005) Differential modulation of gene expression in the NMDA postsynaptic density of schizophrenic and control smokers. Brain Res Mol Brain Res 139: 317 332.
19. Mieczkowski T, Newel R, Wraight B (1998) Using hair analysis, urinalysis, and self-reports to estimate drug use in a sample of detained juveniles. Subst Use Misuse 33: 1547 1567.
20. Miller PR, Dasher R, Collins R, Griffiths P, Brown F (2002) Inpatient diagnostic assessments: 1. Accuracy of structured vs. unstructured interviews. Psychiatry Res 105: 255 264.
21. Mura P, Kintz P, Dumestre V, Raul S, Hauet T (2005) THC can be detected in brain while absent in blood. J Anal Toxicol 29: 842 843.
22. Musshoff F, Driver F, Lachenmeier K, Lachenmeier DW, Banger M, Madea B (2006) Results of hair analysis for drugs of abuse and comparison with self-reports and urine tests. Forensic Sci Int 156: 118 123.
23. Myrick H, Henderson S, Dansky B, Pelic C, Brady KT (2002) Clinical characteristics of under-reporters on urine drug screens in a cocaine treatment study. Am J Addict 11: 255 261.
24. Nakahara Y, Takahashi K, Kikura R (1995) Hair analysis for drugs of abuse. X. Effect of physicochemical properties of drugs on the incorporation rates into hair. Biol Pharm Bull 18: 1223 1227.
25. Pierucci-Lagha A, Gelernter J, Feinn R, Cubells JF, Pearson D, Pollastri A, Farrer L, Kranzler HR (2005) Diagnostic reliability of the semi-structured assessment for drug dependence and alcoholism (SSADDA). Drug Alcohol Depend 80: 303 312.
26. Pragst F, Balikova NA (2006) State of the art in hair analysis for detection of drug and alcohol abuse. Clin Chim Acta 370: 17 49.
27. Preston KL, Epstein DH, Cone EJ, Wtsadik AT, Huestis MA, Moolchan ET (2002) Urinary elimination of cocaine metabolites in chronic cocaine users during cessation. J Anal Toxicol 26: 393 400.
28. Roberts SB, Hill CA, Dean B, Keks NA, Opeskin K, Copolov DL (1998) Confirmation of the diagnosis of schizophrenia after death using DSM-IV: a Victorian experience. Aust N Z J Psychiatry 32: 73 76.
29. Rounsaville BJ, Petry NM, Carroll KM (2003) Single versus multiple drug focus in substance abuse clinical trials research. Drug Alcohol Depend 70: 117 125.
30. Sawamura N, Sawamura-Yamamoto T, Ozeki Y, Ross CA, Sawa A (2005) A form of DISC1 enriched in nucleus: altered subcellular distribution in orbitofrontal cortex in psychosis and substance/alcohol abuse. Proc Natl Acad Sci USA 102: 1187 1192.
31. Swartz MS, Wagner HR, Swanson JW, Stroup TS, McEvoy JP, Canive JM, Miller DD, Reimherr F, McGee M, Khan A, Van Dorn R, Rosenheck RA, Lieberman JA (2006) Substance use in persons with schizophrenia: baseline prevalence and correlates from the NIMH CATIE study. J Nerv Ment Dis 194: 164 172.
32. Tassiopoulos K, Bernstein J, Heeren T, Levenson S, Hingson R, Bernstein E (2004) Hair testing and self-report of cocaine use by heroin users. Addiction 99: 590 597.
33. Tassiopoulos K, Bernstein J, Heeren T, Levenson S, Hingson R, Bernstein E (2006) Predictors of disclosure of continued cocaine use. Addict Behav 31: 80 89.
34. Uhl M, Sachs H (2004) Cannabinoids in hair: strategy to prove marijuana/hashish consumption. Forensic Sci Int 145: 143 147.
35. Verstraete AG (2004) Detection times of drugs of abuse in blood, urine, and oral fluid. Ther Drug Monit 26: 200 205.